Fadraciclib
Fadraciclib (CYC065) is a potent, orally bioavailable inhibitor targeting CDK2 and CDK9 kinases with IC50 values of 5 nM and 26 nM, respectively. It is used in cancer research to study transcriptional regulation and apoptosis, demonstrating activity in both in vitro cell-based assays and in vivo tumor models.
Product Specifications
CAS Number
1070790-89-4
Product Name Alternative
CDK9, CDK, CDK2, Cyclin dependent kinase, CYC 065, CYC065, CYC-065, inhibit, Fadraciclib, Inhibitor
Field of Research
Cell Biology
Purity
98.71% (May vary between batches)
Solubility
DMSO:100 mg/mL (251.56 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.06 mM)
Smiles
CC[C@H] (Nc1nc (NCc2cnc (C) cc2C) c2ncn (C (C) C) c2n1) [C@@H] (C) O
Molecular Formula
C21H31N7O
Molecular Weight
397.52
Storage Conditions
Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
